PSX · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $132.38B | $143.15B | $147.40B | $169.99B | $111.48B | $64.13B | $107.29B | $111.46B |
| Cost of Revenue | $116.09B | $129.96B | $128.09B | $149.93B | $102.10B | $57.71B | $95.53B | $97.93B |
| Research & Development | $6.00M | $15.00M | $27.00M | $42.00M | $47.00M | $48.00M | $54.00M | $55.00M |
| Selling, General & Administrative | $2.44B | $2.81B | $2.52B | $2.17B | $1.74B | $1.54B | $1.68B | $1.68B |
| Interest Expense | $997.00M | $919.00M | $842.00M | $611.00M | $567.00M | $550.00M | $504.00M | $493.00M |
| Other Income / (Expense) | $438.00M | $243.00M | $359.00M | $2.74B | $454.00M | $66.00M | $119.00M | $61.00M |
| Income Before Taxes | — | — | — | — | — | -$4.96B | $4.18B | $7.45B |
| Provision for Income Taxes | $892.00M | $500.00M | $2.23B | $3.25B | $146.00M | -$1.25B | $801.00M | $1.57B |
| Net Income | $4.40B | $2.12B | $7.01B | $11.02B | $1.32B | -$3.98B | $3.08B | $5.59B |
| Basic EPS | $10.82 | $5.01 | $15.56 | $23.36 | $2.97 | -$9.06 | $6.80 | $11.87 |
| Diluted EPS | $10.79 | $4.99 | $15.48 | $23.27 | $2.97 | -$9.06 | $6.77 | $11.80 |
| Basic Shares Outstanding | 406.01M | 420.17M | 450.14M | 471.50M | 440.03M | 439.53M | 451.36M | 470.71M |
| Diluted Shares Outstanding | 408.05M | 421.89M | 453.21M | 473.73M | 440.36M | 439.53M | 453.89M | 474.05M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $22.43 | $17.80 | $28.85 | 7 | ↑5 ↓1 |
| Dec 2027 | $19.81 | $14.56 | $27.10 | 8 | ↑4 ↓2 |
| Dec 2028 | $17.95 | $14.60 | $24.21 | 3 | ↑1 ↓0 |
| Dec 2029 | $17.12 | $17.12 | $17.12 | 1 | ↑1 ↓0 |